leisure time -WSS

leisure time

author：leisure time 2025-08-26 23:48:35 - browse：8

Adam's take main illustration — Molly Ferguson/STAT

Shares of Apellis Pharmaceuticals are rebounding, driven by a growing belief among some investors that the serious safety issue that has derailed Syfovre, the company’s eye disease treatment, is receding.

Declaring the crisis over is premature, but that could change with more uneventful weeks. Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value.

Apellis shares rose 32% last week, with most of the gains coming Friday on heavy trading volume. The reason: There have been no new cases of retinal occlusive vasculitis, or ROV, reported in people receiving injections of Syfovre.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Surge of respiratory disease in China has likely explanation

WSS

World's first CRISPR

Does good food count as health care? Study aims to find out

Biden White House, tech companies launch new safeguards around emerging AI technology

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Morphosys mixed study results for blood cancer drug

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

entertainment

leisure time

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

United colonoscopy coverage change 'may cost lives,' doctors say

EMA weighs against approval for Mirati's lung cancer drug

Activists slam private health insurers over coverage restrictions

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Cancer drug shortages should be causing more outrage

Gain of function research would be limited under House proposal

Virginia high school admissions case could be legal follow

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

hotspot

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

New chart reveals military’s vast involvement in Operation Warp Speed

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Why medical students are struggling with mental health

A new deal aims to ramp up use of AI in rehab care decisions

focus

leisure time

hotspot

Wikipedia